The machine health technology provider was reportedly valued at up to $300m in a series D round featuring Qualcomm Ventures and Munich Re Venture Capital.
Augury, an Israel-headquartered developer of machine analysis technology, raised $55m in series D funding on Wednesday from investors including subsidiaries of mobile semiconductor producer Qualcomm and reinsurer Munich Re.
Qualcomm Ventures and Munich Re Venture Capital joined venture capital firm Qumra Capital, which led the round, Insight Partners, Eclipse Ventures and Lerer Hippeau. A source close to the company told TechCrunch the round valued it between $200m and $300m.
Founded in 2011, Augury has built a system that combines sensors…
